Symbol="GMDA"
AssetType="Common Stock"
Name="Gamida Cell Ltd"
Description="Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company is headquartered in Jerusalem, Israel."
CIK="1600847"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5 NAHUM HAFZADI STREET, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="131984000"
EBITDA="-74816000"
PERatio="None"
PEGRatio="None"
BookValue="-0.108"
DividendPerShare="0"
DividendYield="0"
EPS="-1.17"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.41"
ReturnOnEquityTTM="-16.66"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.35"
EVToRevenue="-"
EVToEBITDA="-1.506"
Beta="1.511"
num_52WeekHigh="3.38"
num_52WeekLow="0.56"
num_50DayMovingAverage="1.647"
num_200DayMovingAverage="1.552"
SharesOutstanding="105587000"
DividendDate="None"
ExDividendDate="None"
symbol="GMDA"
open="1.24"
high="1.30"
low="1.21"
price="1.25"
volume="10438872.00"
latest_trading_day="2023-08-15"
previous_close="1.28"
change="-0.03"
change_percent="-2.3438%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="4127459"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="667"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
